Protocol Ledger

NCT04073706 · Phase III · RECRUITING

Sentinel Node Biopsy in Endometrial Cancer

Interventional Phase III clinical trial protocol NCT04073706 sponsored by Queensland Centre for Gynaecological Cancer in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-01-18 Enrollment: 760 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04073706
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)760 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04073706
Protocol FieldVerified Registry Value
NCT IdentifierNCT04073706
Consolidated Lead SponsorQueensland Centre for Gynaecological Cancer
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment760 participants (ESTIMATED)
Registered Start Date2021-01-18
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04073706
Hospital Research SiteLocationSite Profile
Houston Methodist HospitalHouston, TXOpen Hospital Dossier ->
Chris O'Brien LifehouseCamperdown, AustraliaOpen Hospital Dossier ->
Liverpool HospitalLiverpool, AustraliaOpen Hospital Dossier ->
Royal Brisbane and Women's HospitalHerston, AustraliaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI